Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as Citalopram and Fluoxetine. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.
Several weeks of therapy with sertraline may be required before beneficial effects are noticed. Sertraline displays enhanced safety or tolerability than other classes of antidepressants, which frequently cause high levels of drowsiness, dizziness, blurred vision, and other undesirable effects.
Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD). Common off-label uses for sertraline include the prevention of post stroke depression, generalized anxiety disorder (GAD), fibromyalgia, premature ejaculation, migraine prophylaxis, diabetic neuropathy, and neurocardiogenic syncope.
University of Minnesota, Minneapolis, Minnesota, United States
Center for Women's Reproductive Mental Health, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
University of Ulm School of Medicine, Ulm, Baden-Württemberg, Germany
Jacobi Medical Center, Bronx, New York, United States
University of Rochester, Rochester, New York, United States
Honor Health, Scottsdale, Arizona, United States
Pfizer Clinical Research Unit, Brussels, Belgium
University of Utah Hospital, Salt Lake City, Utah, United States
South Texas Veterans Health Care System, San Antonio, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.